Device
Transcranial Magnetic Stimulator
Transcranial Magnetic Stimulator is a medical device with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_1
2
40%
Ph phase_2
1
20%
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
60.0%
3 of 5 finished
Non-Completion Rate
40.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(2)
Detailed Status
Completed3
Withdrawn2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (50.0%)
Phase 21 (25.0%)
N/A1 (25.0%)
Trials by Status
completed360%
withdrawn240%
Recent Activity
0 active trials
Showing 5 of 5
withdrawnnot_applicable
rTMS for Peripartum Depression
NCT03949465
completedphase_1
D-Cycloserine+iTBS PK Study
NCT05731323
completedphase_2
Adjunctive D-Cycloserine in Major Depressive Disorder
NCT03937596
withdrawn
Treatment of Major Depressive Disorder in the UK Using TMS Therapy
NCT04217837
completedphase_1
Accelerated Transcranial Magnetic Stimulation (TMS) for Depression
NCT00248768
Clinical Trials (5)
Showing 5 of 5 trials
NCT03949465Not Applicable
rTMS for Peripartum Depression
NCT05731323Phase 1
D-Cycloserine+iTBS PK Study
NCT03937596Phase 2
Adjunctive D-Cycloserine in Major Depressive Disorder
NCT04217837
Treatment of Major Depressive Disorder in the UK Using TMS Therapy
NCT00248768Phase 1
Accelerated Transcranial Magnetic Stimulation (TMS) for Depression
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5